マイクロサージャリーおよびスーパーマイクロサージャリーの世界市場：エンドユーザー別、機器別、手技別、地域別 - 2032年までの予測分析

産業概要

マイクロサージャリーおよびスーパーマイクロサージャリーの市場規模は、2022年に19億6,154万米ドルとなりました。同市場は、2032年には37億8,366万米ドルに達すると予測され、2023年から2032年にかけてCAGR6.07％で成長する見込みです。

高齢化と外科手術の増加が、世界のマイクロサージャリーおよびスーパーマイクロサージャリー市場の主な促進要因です。研究開発の革新と移植手術の急増により、特に整形外科や再建分野では精密な手術方法に対する需要が高まっています。慢性疾患や加齢に伴う健康問題は、成功率の高いマイクロサージャリー技術の必要性をさらに加速させています。

しかし市場には、感染症、創傷治癒の遅れ、神経損傷、目に見える瘢痕、麻酔関連の問題、再手術の必要性などの外科的合併症といった障壁があります。

プラス面では、生活習慣病の増加や継続的な技術向上により、市場には大きな機会があります。政府の承認や高度な眼科用顕微鏡のような新しいツールの開発により、手術の精度が向上しています。高齢者と若年層の両方で生活習慣病が増加しているため、これらの技術革新は、より安全で効果的な顕微鏡手術の選択肢を提供することで、市場の成長を促進すると思われます。

産業区分

世界のマイクロサージャリーおよびスーパーマイクロサージャリー市場は、病院や外来手術センターなどのエンドユーザー別にセグメント化されています。

機器タイプ別では、世界のマイクロサージャリーおよびスーパーマイクロサージャリー市場は、手術用顕微鏡、超小型縫合糸、超小型鉗子、マイクロサージェリー用針ホルダー、手術用メス/眼科用ナイフ、その他に分類されます。

手技カテゴリー別では、世界のマイクロサージャリーおよびスーパーマイクロサージャリー市場は、整形外科マイクロサージェリー、眼科マイクロサージェリー、形成・再建マイクロサージェリー、耳鼻咽喉科マイクロサージェリー、神経科マイクロサージェリー、婦人科・泌尿器科マイクロサージェリーにセグメント化されています。

地域分析

世界のマイクロサージャリーおよびスーパーマイクロサージャリー市場は、地域によって異なる動向で進化し続けています。北米は、医療技術の急速な進歩と、様々な専門分野で使用される低侵襲手術手技への傾斜の高まりが主な原因で、大幅な成長を遂げています。

欧州では、医療技術革新の急増、高齢化、慢性疾患の増加に支えられ、市場は大きく成熟しています。精密機器や顕微鏡を用いたマイクロサージャリー技術は、高度に専門化されたスーパーマイクロサージャリー法とともに、現在では再建外科、整形外科、眼科、形成外科で広く利用されています。

アジア太平洋地域は、研究開発への積極的な投資により、目覚しい勢いを見せています。一流の医療センターや大学では、精度と治療成果を高める複雑な手術手技の洗練と開発の最先端を行っています。

対照的に、中東・アフリカ、ラテンアメリカの市場は拡大していますが、まだハードルに直面しています。これらの地域では、高度なマイクロサージャリー技術の可能性が認識されつつありますが、熟練した専門家の不足、高価な医療機器、ヘルスケアインフラの格差により、進歩が遅れています。これらの課題は、これらの高度な手技への関心が着実に高まっているにもかかわらず、アクセス性を制限し、普及を妨げています。

主要参入企業

Olympus Corporation、Kontron AG、B.Braun SE、Zimmer Biomet、Carl Zeiss Meditec、Global Surgical Corporation、Karl Kaps GmbH &Co.KG、Medtronic、Smith+Nephew、Topcon Corporation、Stille AB、Stryker、BVI、Johnson &Johnson Services Inc、Haag-Streit Group、KLS Martin Group、Microsurgery Instruments Inc、Peter Lazic GmbH、Alco Inc、Synovis Micro Companies Alliance Inc.などが、世界のマイクロサージャリーおよびスーパーマイクロサージャリー業界の主要企業です。

目次

第1章 エグゼクティブサマリー

第2章 市場イントロダクション

第3章 調査手法

• 概要
• データフロー
• 購入したデータベース：
• 二次情報
• 1次調査
• 市場規模推定のアプローチ
• データ予測
• データエンドユーザー
• チームとアナリストの貢献

第4章 市場力学

• イントロダクション
• 促進要因
  • 外科手術の増加
  • 高齢化人口の増加
• 抑制要因
  • 手術別合併症とリスク
• 機会
  • 生活習慣病の増加と技術の進歩

第5章 市場要因分析

• バリューチェーン分析
  • 研究開発
  • 製造
  • 流通と販売
  • 販売後モニタリング
• ポーターのファイブフォースモデル
• COVID-19が世界のマイクロサージャリーおよびスーパーマイクロサージャリー市場に与える影響
  • サプライチェーンへの影響
  • 主要参入企業への影響
  • 需要と供給への影響

第6章 世界のマイクロサージャリーおよびスーパーマイクロサージャリー市場（機器別）

• 概要
• 手術用顕微鏡
• スーパーマイクロ縫合糸
• マイクロ鉗子
• マイクロサージェリー針ホルダー
• 外科用メス/眼科用ナイフ
• その他

第7章 世界のマイクロサージャリーおよびスーパーマイクロサージャリー市場（手技別）

• 概要
• 整形外科マイクロサージェリー
• 眼科マイクロサージェリー
• 形成外科および再建マイクロサージェリー
• 耳鼻咽喉科マイクロサージェリー
• 神経学的微小外科手術
• 婦人科および泌尿器科マイクロサージェリー
• その他

第8章 世界のマイクロサージャリーおよびスーパーマイクロサージャリー市場（エンドユーザー別）

• 概要
• 病院
• 外来手術センター
• その他

第9章 世界のマイクロサージャリーおよびスーパーマイクロサージャリー市場（地域別）

• 概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • その他
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • その他
• その他の地域
  • 中東
  • 南米

第10章 競合情勢

• イントロダクション
• 2022年の市場シェア分析
• 競合ダッシュボード
• パブリックプレーヤーの株式サマリー
• 比較分析：主要参入企業の財務
• 主な発展と成長戦略
  • 製品の発売/製品承認

第1章 買収/投資/拡張

• 競合製品分析
  • 手術用顕微鏡
  • マイクロ鉗子
  • スーパーマイクロ縫合糸
  • マイクロサージェリー針ホルダー
  • 外科用メス/眼科用ナイフ

第11章 企業プロファイル

• KONTRON AG
• CARL ZEISS MEDITEC AG
• GLOBAL SURGICAL CORPORATION
• KARL KAPS GMBH & CO. KG
• MEDTRONIC
• OLYMPUS CORPORATION
• SMITH+NEPHEW
• ZIMMER BIOMET
• TOPCON CORPORATION
• STILLE AB

第1章 主要戦略

• B. BRAUN SE
• STRYKER
• BVI
• JOHNSON & JOHNSON SERVICES INC
• HAAG-STREIT GROUP
• KLS MARTIN GROUP
• MICROSURGERY INSTRUMENTS, INC
• PETER LAZIC GMBH
• ALCON INC
• SYNOVIS MICRO COMPANIES ALLIANCE, INC

第12章 データの引用

LIST OF TABLES

• TABLE 1 QFD END USERLING FOR MARKET SHARE ASSESSMENT
• TABLE 2 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
• TABLE 3 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR TOPERATING MICROSCOPES, BY REGION, 2019-2032 (USD MILLION)
• TABLE 4 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR SUPER MICRO SUTURES, BY REGION, 2019-2032 (USD MILLION)
• TABLE 5 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR MICRO FORCEPS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 6 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR MICROSURGERY NEEDLE HOLDER, BY REGION, 2019-2032 (USD MILLION)
• TABLE 7 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR SURGICAL SCALPEL/ OPHTHALMIC KNIVES, BY REGION, 2019-2032 (USD MILLION)
• TABLE 8 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 9 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
• TABLE 10 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR ORTHOPEDIC MICROSURGERY, BY REGION, 2019-2032 (USD MILLION)
• TABLE 11 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR OPHTHALMIC MICROSURGERY, BY REGION, 2019-2032 (USD MILLION)
• TABLE 12 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR PLASTIC & RECONSTRUCTIVE MICROSURGERY, BY REGION, 2019-2032 (USD MILLION)
• TABLE 13 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR ENT MICROSURGERY, BY REGION, 2019-2032 (USD MILLION)
• TABLE 14 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR NEUROLOGICAL MICROSURGERY, BY REGION, 2019-2032 (USD MILLION)
• TABLE 15 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR GYNECOLOGICAL & UROLOGICAL MICROSURGERY, BY REGION, 2019-2032 (USD MILLION)
• TABLE 16 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 17 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 18 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR HOSPITALS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 19 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 20 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 21 GLOBAL: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY REGION, 2019-2032 (USD MILLION)
• TABLE 22 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
• TABLE 23 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
• TABLE 24 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
• TABLE 25 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
• TABLE 26 US: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
• TABLE 27 US: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
• TABLE 28 US: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
• TABLE 29 CANADA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
• TABLE 30 CANADA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
• TABLE 31 CANADA: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
• TABLE 32 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
• TABLE 33 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
• TABLE 34 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
• TABLE 35 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
• TABLE 36 GERMANY: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
• TABLE 37 GERMANY: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
• TABLE 38 GERMANY: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
• TABLE 39 FRANCE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
• TABLE 40 FRANCE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
• TABLE 41 FRANCE: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
• TABLE 42 UK: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
• TABLE 43 UK: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
• TABLE 44 UK: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
• TABLE 45 ITALY: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
• TABLE 46 ITALY: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
• TABLE 47 ITALY: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
• TABLE 48 SPAIN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
• TABLE 49 SPAIN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
• TABLE 50 SPAIN: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
• TABLE 51 REST OF EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
• TABLE 52 REST OF EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
• TABLE 53 REST OF EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
• TABLE 54 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 55 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 56 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 57 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58 CHINA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 59 CHINA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 60 CHINA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61 JAPAN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 62 JAPAN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 63 JAPAN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64 INDIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 65 INDIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 66 INDIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67 AUSTRALIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 68 AUSTRALIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 69 AUSTRALIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70 SOUTH KOREA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 71 SOUTH KOREA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 72 SOUTH KOREA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73 REST OF ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 74 REST OF ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 75 REST OF ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76 REST OF THE WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 77 REST OF THE WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 78 REST OF THE WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 79 REST OF THE WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80 MIDDLE EAST: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 81 MIDDLE EAST: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 82 MIDDLE EAST: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83 SOUTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 84 SOUTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 85 SOUTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86 PUBLIC PLAYERS STOCK SUMMARY
• TABLE 87 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
• TABLE 88 PRODUCT LAUNCH/PRODUCT APPROVAL
• TABLE 89 ACQUISITION /INVESTMENT/EXPANSION/COLLABORATION
• TABLE 90 KONTRON AG: PRODUCTS OFFERED
• TABLE 91 CARL ZEISS MEDITEC AG: PRODUCTS OFFERED
• TABLE 92 CARL ZEISS MEDITEC AG: KEY DEVELOPMENTS
• TABLE 93 GLOBAL SURGICAL CORPORATION: PRODCUTS OFFERED
• TABLE 94 KARL KAPS GMBH & CO. KG: PRODCUTS OFFERED
• TABLE 95 MEDTRONIC: PRODCUTS OFFERED
• TABLE 96 OLYMPUS CORPORATION: PRODCUTS OFFERED
• TABLE 97 SMITH+NEPHEW: PRODCUTS OFFERED
• TABLE 98 ZIMMER BIOMET: PRODCUTS OFFERED
• TABLE 99 TOPCON CORPORATION: PRODCUTS OFFERED
• TABLE 100 STILLE AB: PRODCUTS OFFERED
• TABLE 101 STILLE AB: KEY DEVELOPMENTS
• TABLE 102 B. BRAUN SE: PRODUCTS OFFERED
• TABLE 103 STRYKER: PRODCUTS OFFERED
• TABLE 104 BVI: PRODCUTS OFFERED
• TABLE 105 BVI: KEY DEVELOPMENTS
• TABLE 106 JOHNSON & JOHNSON SERVICES INC: PRODUCTS OFFERED
• TABLE 107 HAAG-STREIT GROUP: PRODUCTS OFFERED
• TABLE 108 KLS MARTIN GROUP: PRODUCTSOFFERED
• TABLE 109 MICROSURGERY INSTRUMENTS, INC: PRODUCTS OFFERED
• TABLE 110 PETER LAZIC GMBH: PRODUCT OFFERED
• TABLE 111 ALCON: PRODUCT OFFERED
• TABLE 112 SYNOVIS MICRO COMPANIES ALLIANCE, INC: PRODUCT OFFERED
• TABLE 113 SYNOVIS MICRO COMPANIES ALLIANCE, INC: KEY DEVELOPMENTS

LIST OF FIGURES

• FIGURE 1 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET: STRUCTURE
• FIGURE 2 GLOBAL MICROSURGERY AND SUPER-MICROSURGERY MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032)
• FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
• FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032)
• FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET
• FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET
• FIGURE 7 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, EQUIPMENT SEGMENT ATTRACTIVENESS, 2019-2032 (USD MILLION)
• FIGURE 8 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2022 & 2032(USD MILLION)
• FIGURE 9 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY EQUIPMENT, 2022 (%)
• FIGURE 10 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, PROCEDURE SEGMENT ATTRACTIVENESS, 2019-2032 (USD MILLION)
• FIGURE 11 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2022 & 2032(USD MILLION)
• FIGURE 12 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY PROCEDURE, 2022 (%)
• FIGURE 13 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, END USER SEGMENT ATTRACTIVENESS, 2019-2032 (USD MILLION)
• FIGURE 14 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2022 & 2032(USD MILLION)
• FIGURE 15 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY END USER, 2022 (%)
• FIGURE 16 GLOBAL: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY REGION, 2022 & 2032 (USD MILLION)
• FIGURE 17 GLOBAL: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE (%), BY REGION, 2022
• FIGURE 18 NORTH AMERICA MARKET ANALYSIS: MICROSURGERY & SUPER-MICROSURGERY MARKET, 2019-2032 (USD MILLION)
• FIGURE 19 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION)
• FIGURE 20 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE (%), BY COUNTRY, 2022
• FIGURE 21 EUROPE MARKET ANALYSIS: MICROSURGERY & SUPER-MICROSURGERY MARKET, 2019-2032 (USD MILLION)
• FIGURE 22 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION)
• FIGURE 23 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE (%), BY COUNTRY, 2022
• FIGURE 24 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, 2019-2032 (USD MILLION)
• FIGURE 25 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY COUNTRY, 2022 (% SHARE)
• FIGURE 26 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY COUNTRY, 2022 & 2032 (USD MILLION)
• FIGURE 27 REST OF THE WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET, 2019-2032 (USD MILLION)
• FIGURE 28 REST OF WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY COUNTRY, 2022 (% SHARE)
• FIGURE 29 REST OF WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY COUNTRY, 2021 & 2030 (USD MILLION)
• FIGURE 30 GLOBAL MICROSURGERY & SUPER-MICROSURGERY PLAYERS: COMPETITIVE ANALSIS, 2022
• FIGURE 31 COMPETITOR DASHBOARD: GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET
• FIGURE 32 COMPETITORS PRODUCT ANALYSIS: OPERATING MICROSCOPES
• FIGURE 33 COMPETITORS PRODUCT ANALYSIS: MICRO FORCEPS
• FIGURE 34 COMPETITORS PRODUCT ANALYSIS: SUPER MICRO SUTURES
• FIGURE 35 COMPETITORS PRODUCT ANALYSIS: MICROSURGERY NEEDLE HOLDER
• FIGURE 36 COMPETITORS PRODUCT ANALYSIS: SURGICAL SCALPEL/ OPHTHALMIC KNIVES
• FIGURE 37 KONTRON AG: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 38 CARL ZEISS MEDITEC AG: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 39 CARL ZEISS MEDITEC AG: SWOT ANALYSIS
• FIGURE 40 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 41 MEDTRONIC: SWOT ANALYSIS
• FIGURE 42 OLYMPUS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 43 SMITH+NEPHEW: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 44 ZIMMER BIOMET: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 45 ZIMMER BIOMET: SWOT ANALYSIS
• FIGURE 46 TOPCON CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 47 STILLE AB: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 48 B. BRAUN SE: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 49 B. BRAUN SE: SWOT ANALYSIS
• FIGURE 50 STRYKER: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 51 JOHNSON & JOHNSON SERVICES INC.: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 52 JOHNSON & JOHNSON SERVICES INC: SWOT ANALYSIS
• FIGURE 53 ALCON INC: FINANCIAL OVERVIEW SNAPSHOT

Global Microsurgery & Super-Microsurgery Market Research by End User (Hospitals, Ambulatory Surgical Centers, Others), by Equipment (Operating Microscopes, Super Micro Sutures, Micro Forceps, Microsurgery Needle Holder, Surgical Scalpel/ Ophthalmic Knives, Others), by Procedure (Orthopedic Microsurgery, Ophthalmic Microsurgery, Plastic & Reconstructive Microsurgery, ENT Microsurgery, Neurological Microsurgery, Gynecological & Urological Microsurgery, Others), by Region (North America, Europe, Asia Pacific, Rest of the World) Forecast Analysis till 2032

Industry Overview

The market for microsurgery and super-microsurgery was valued at USD 1,961.54 million in 2022 and is expected to reach USD 3,783.66 million in 2032, growing at a Compound Annual Growth Rate (CAGR) of 6.07% between 2023 and 2032.

The aging population and the rise in surgical operations are the main drivers of global microsurgery and super-microsurgery market. Innovations in research and development, along with a surge in transplant operations, have increased the demand for precise surgical methods, particularly in orthopedic and reconstructive fields. Chronic illnesses and age-related health issues further accelerate the need for high-success microsurgical techniques.

However, the market encounters barriers such as surgical complications, including infections, delayed wound healing, nerve damage, visible scarring, anesthesia-related problems, and the possible requirement for follow-up surgeries.

On the positive side, the market presents substantial opportunities due to the rise in lifestyle-related disorders and continued technological improvements. Government approvals and the development of new tools like advanced ophthalmic microscopes are enhancing procedural accuracy. As lifestyle diseases increase among both older and younger demographics, these innovations will drive market growth by offering safer, more effective microsurgical options.

Industry Segmentations

Global microsurgery and super microsurgery market is segmented by the end user, includes hospitals and ambulatory surgical centers and others.

In terms of equipment type, global microsurgery and super microsurgery market is categorized into operating microscopes, super micro sutures, micro forceps, microsurgery needle holder, surgical scalpel/ ophthalmic knives, and others.

Based on the procedure category, global microsurgery and super microsurgery market has been segmented into Orthopedic Microsurgery, Ophthalmic Microsurgery, Plastic & Reconstructive Microsurgery, ENT Microsurgery, Neurological Microsurgery, Gynecological & Urological Microsurgery.

North America, Asia Pacific, Europe, and rest of the world are the part of regional types of global market.

Regional Analysis

Global microsurgery and super-microsurgery market continues to evolve with distinct trends across regions. North America has experienced substantial growth, largely due to rapid advancements in medical technology and a growing inclination toward minimally invasive surgical techniques used in various specialties.

In Europe, the market has matured significantly, supported by a surge in medical innovations, an aging population, and a rise in chronic illnesses. Microsurgical techniques involving precision tools and microscopes, along with highly specialized super-microsurgery methods, are now widely utilized in reconstructive surgery, orthopedics, ophthalmology, and plastic surgery.

The Asia Pacific region is showing impressive momentum, spurred by active investment in research and development. Top-tier medical centers and universities are at the cutting edge of refining and developing complex surgical procedures that enhance accuracy and treatment outcomes.

In contrast, the market in the Middle East, Africa, and Latin America is expanding but still faces hurdles. Although these regions are recognizing the potential of advanced microsurgical techniques, progress is slowed by the lack of skilled professionals, expensive medical equipment, and gaps in healthcare infrastructure. These challenges limit accessibility and prevent widespread adoption, even as interest in these advanced procedures grows steadily.

Key Players

Olympus Corporation, Kontron AG, B. Braun SE, Zimmer Biomet, Carl Zeiss Meditec, Global Surgical Corporation, Karl Kaps GmbH & Co. KG, Medtronic, Smith+Nephew, Topcon Corporation, Stille AB, Stryker, BVI, Johnson & Johnson Services Inc, Haag-Streit Group, KLS Martin Group, Microsurgery Instruments Inc, Peter Lazic GmbH, Alco Inc, Synovis Micro Companies Alliance Inc. are the key companies of global microsurgery and super microsurgery industry.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

• 3.1 OVERVIEW
• 3.2 DATA FLOW
  • 3.2.1 DATA MINING PROCESS
• 3.3 PURCHASED DATABASE:
• 3.4 SECONDARY SOURCES:
  • 3.4.1 SECONDARY RESEARCH DATA FLOW:
• 3.5 PRIMARY RESEARCH:
  • 3.5.1 PRIMARY RESEARCH DATA FLOW:
  • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
  • 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
• 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
  • 3.6.1 REVENUE ANALYSIS APPROACH
• 3.7 DATA FORECASTING
  • 3.7.1 DATA FORECASTING TECHNIQUE
• 3.8 DATA END USERLING
  • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
  • 3.8.2 DATA END USERLING:
• 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

• 4.1 INTRODUCTION
• 4.2 DRIVERS
  • 4.2.1 GROWING NUMBER OF SURGICAL PROCEDURES
  • 4.2.2 INCREASING NUMBER OF GERIATRIC POPULATION
• 4.3 RESTRAINTS
  • 4.3.1 COMPLICATIONS AND RISKS DUE TO THE PROCEDURE
• 4.4 OPPORTUNITY
  • 4.4.1 INCREASING INCIDENCE OF LIFESTYLE DISORDERS AND GROWING TECHNOLOGICAL ADVANCEMENTS

5 MARKET FACTOR ANALYSIS

• 5.1 VALUE CHAIN ANALYSIS
  • 5.1.1 R&D
  • 5.1.2 MANUFACTURING
  • 5.1.3 DISTRIBUTION AND SALES
  • 5.1.4 POST-SALES MONITORING
• 5.2 PORTER'S FIVE FORCES MODEL
  • 5.2.1 THREAT OF NEW ENTRANTS
  • 5.2.2 BARGAINING POWER OF SUPPLIERS
  • 5.2.3 THREAT OF SUBSTITUTES
  • 5.2.4 BARGAINING POWER OF BUYERS
  • 5.2.5 INTENSITY OF RIVALRY
• 5.3 IMPACT OF COVID-19 ON THE GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET
  • 5.3.1 IMPACT ON SUPPLY CHAIN
  • 5.3.2 IMPACT ON KEY PLAYERS
  • 5.3.3 IMPACT ON DEMAND AND SUPPLY

6 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT

• 6.1 OVERVIEW
• 6.2 OPERATING MICROSCOPES
• 6.3 SUPER MICRO SUTURES
• 6.4 MICRO FORCEPS
• 6.5 MICROSURGERY NEEDLE HOLDER
• 6.6 SURGICAL SCALPEL/ OPHTHALMIC KNIVES
• 6.7 OTHERS

7 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE

• 7.1 OVERVIEW
• 7.2 ORTHOPEDIC MICROSURGERY
• 7.3 OPHTHALMIC MICROSURGERY
• 7.4 PLASTIC & RECONSTRUCTIVE MICROSURGERY
• 7.5 ENT MICROSURGERY
• 7.6 NEUROLOGICAL MICROSURGERY
• 7.7 GYNECOLOGICAL & UROLOGICAL MICROSURGERY
• 7.8 OTHERS

8 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER

• 8.1 OVERVIEW
• 8.2 HOSPITALS
• 8.3 AMBULATORY SURGICAL CENTERS
• 8.4 OTHERS

9 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY REGION

• 9.1 OVERVIEW
• 9.2 NORTH AMERICA
  • 9.2.1 US
  • 9.2.2 CANADA
• 9.3 EUROPE
  • 9.3.1 GERMANY
  • 9.3.2 FRANCE
  • 9.3.3 UK
  • 9.3.4 ITALY
  • 9.3.5 SPAIN
  • 9.3.6 REST OF EUROPE
• 9.4 ASIA-PACIFIC
  • 9.4.1 CHINA
  • 9.4.2 JAPAN
  • 9.4.3 INDIA
  • 9.4.4 AUSTRALIA
  • 9.4.5 SOUTH KOREA
  • 9.4.6 REST OF ASIA-PACIFIC
• 9.5 REST OF WORLD
  • 9.5.1 MIDDLE EAST
  • 9.5.2 SOUTH AMERICA

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 MARKET SHARE ANALYSIS, 2022
• 10.3 COMPETITOR DASHBOARD
• 10.4 PUBLIC PLAYERS STOCK SUMMARY
• 10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
• 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 10.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL

1 0.6.2 ACQUISITION/INVESTMENT/EXPANSION

• 10.7 COMPETITOR PRODUCT ANALYSIS
  • 10.7.1 OPERATING MICROSCOPES
  • 10.7.2 MICRO FORCEPS
  • 10.7.3 SUPER MICRO SUTURES
  • 10.7.4 MICROSURGERY NEEDLE HOLDER
  • 10.7.5 SURGICAL SCALPEL/ OPHTHALMIC KNIVES

11 COMPANY PROFILES

• 11.1 KONTRON AG
  • 11.1.1 COMPANY OVERVIEW
  • 11.1.2 FINANCIAL OVERVIEW
  • 11.1.3 PRODUCTS OFFERED
  • 11.1.4 KEY DEVELOPMENTS
  • 11.1.5 KEY STRATEGIES
• 11.2 CARL ZEISS MEDITEC AG
  • 11.2.1 COMPANY OVERVIEW
  • 11.2.2 FINANCIAL OVERVIEW
  • 11.2.3 PRODUCTS OFFERED
  • 11.2.4 KEY DEVELOPMENTS
  • 11.2.5 SWOT ANALYSIS
  • 11.2.6 KEY STRATEGIES
• 11.3 GLOBAL SURGICAL CORPORATION
  • 11.3.1 COMPANY OVERVIEW
  • 11.3.2 FINANCIAL OVERVIEW
  • 11.3.3 PRODUCTS OFFERED
  • 11.3.4 KEY DEVELOPMENTS
  • 11.3.5 KEY STRATEGIES
• 11.4 KARL KAPS GMBH & CO. KG
  • 11.4.1 COMPANY OVERVIEW
  • 11.4.2 FINANCIAL OVERVIEW
  • 11.4.3 PRODUCTS OFFERED
  • 11.4.4 KEY DEVELOPMENTS
  • 11.4.5 KEY STRATEGIES
• 11.5 MEDTRONIC
  • 11.5.1 COMPANY OVERVIEW
  • 11.5.2 FINANCIAL OVERVIEW
  • 11.5.3 PRODUCTS OFFERED
  • 11.5.4 KEY DEVELOPMENTS
  • 11.5.5 SWOT ANALYSIS
  • 11.5.6 KEY STRATEGIES
• 11.6 OLYMPUS CORPORATION
  • 11.6.1 COMPANY OVERVIEW
  • 11.6.2 FINANCIAL OVERVIEW
  • 11.6.3 PRODUCTS OFFERED
  • 11.6.4 KEY DEVELOPMENTS
  • 11.6.5 KEY STRATEGIES
• 11.7 SMITH+NEPHEW
  • 11.7.1 COMPANY OVERVIEW
  • 11.7.2 FINANCIAL OVERVIEW
  • 11.7.3 PRODUCTS OFFERED
  • 11.7.4 KEY DEVELOPMENTS
  • 11.7.5 KEY STRATEGIES
• 11.8 ZIMMER BIOMET
  • 11.8.1 COMPANY OVERVIEW
  • 11.8.2 FINANCIAL OVERVIEW
  • 11.8.3 PRODUCTS OFFERED
  • 11.8.4 KEY DEVELOPMENTS
  • 11.8.5 SWOT ANALYSIS
  • 11.8.6 KEY STRATEGIES
• 11.9 TOPCON CORPORATION
  • 11.9.1 COMPANY OVERVIEW
  • 11.9.2 FINANCIAL OVERVIEW
  • 11.9.3 PRODUCTS OFFERED
  • 11.9.4 KEY DEVELOPMENTS
  • 11.9.5 KEY STRATEGIES
• 11.10 STILLE AB
  • 11.10.1 COMPANY OVERVIEW
  • 11.10.2 FINANCIAL OVERVIEW
  • 11.10.3 PRODUCTS OFFERED
  • 11.10.4 KEY DEVELOPMENTS

1 1.10.5 KEY STRATEGIES

• 11.11 B. BRAUN SE
  • 11.11.1 COMPANY OVERVIEW
  • 11.11.2 FINANCIAL OVERVIEW
  • 11.11.3 PRODUCT OFFERED
  • 11.11.4 KEY DEVELOPMENTS
  • 11.11.5 SWOT ANALYSIS
  • 11.11.6 KEY STRATEGY
• 11.12 STRYKER
  • 11.12.1 COMPANY OVERVIEW
  • 11.12.2 FINANCIAL OVERVIEW
  • 11.12.3 PRODUCTS OFFERED
  • 11.12.4 KEY DEVELOPMENTS
  • 11.12.5 KEY STRATEGIES
• 11.13 BVI
  • 11.13.1 COMPANY OVERVIEW
  • 11.13.2 FINANCIAL OVERVIEW
  • 11.13.3 PRODUCTS OFFERED
  • 11.13.4 KEY DEVELOPMENTS
  • 11.13.5 KEY STRATEGY
• 11.14 JOHNSON & JOHNSON SERVICES INC
  • 11.14.1 COMPANY OVERVIEW
  • 11.14.2 FINANCIAL OVERVIEW
  • 11.14.3 PRODUCTS OFFERED
  • 11.14.4 KEY DEVELOPMENTS
  • 11.14.5 SWOT ANALYSIS
  • 11.14.6 KEY STRATEGIES
• 11.15 HAAG-STREIT GROUP
  • 11.15.1 COMPANY OVERVIEW
  • 11.15.2 FINANCIAL OVERVIEW
  • 11.15.3 PRODUCTSOFFERED
  • 11.15.4 KEY DEVELOPMENTS
  • 11.15.5 KEY STRATEGIES
• 11.16 KLS MARTIN GROUP
  • 11.16.1 COMPANY OVERVIEW
  • 11.16.2 FINANCIAL OVERVIEW
  • 11.16.3 PRODUCT OFFERED
  • 11.16.4 KEY DEVELOPMENTS
  • 11.16.5 KEY STRATEGIES
• 11.17 MICROSURGERY INSTRUMENTS, INC
  • 11.17.1 COMPANY OVERVIEW
  • 11.17.2 FINANCIAL OVERVIEW
  • 11.17.3 PRODUCTS OFFERED
  • 11.17.4 KEY DEVELOPMENTS
  • 11.17.5 KEY STRATEGIES
• 11.18 PETER LAZIC GMBH
  • 11.18.1 COMPANY OVERVIEW
  • 11.18.2 FINANCIAL OVERVIEW
  • 11.18.3 PRODUCT OFFERED
  • 11.18.4 KEY DEVELOPMENTS
  • 11.18.5 KEY STRATEGIES
• 11.19 ALCON INC
  • 11.19.1 COMPANY OVERVIEW
  • 11.19.2 FINANCIAL OVERVIEW
  • 11.19.3 PRODUCT OFFERED
  • 11.19.4 KEY DEVELOPMENTS
  • 11.19.5 KEY STRATEGIES
• 11.20 SYNOVIS MICRO COMPANIES ALLIANCE, INC
  • 11.20.1 COMPANY OVERVIEW
  • 11.20.2 FINANCIAL OVERVIEW
  • 11.20.3 PRODUCT OFFERED
  • 11.20.4 KEY DEVELOPMENTS
  • 11.20.5 KEY STRATEGIES

12 DATA CITATIONS